-
Experts remind: how serious systemic lupus erythematosus is, you can't just look at the symptoms
Time of Update: 2023-01-04
"The big wolf is called the little wolf bite"Disease activity cannot be judged solely by symptomsSLE is an autoimmune disease that can cause damage to multiple organs and tissues such as kidneys, blood system, nervous system, digestive system, cardiovascular, lung, skin, and eyes, and failure to receive timely and effective treatment will significantly increase the risk of death.
-
JAHA: Impact of endocrine therapy on cardiovascular disease and type 2 diabetes in breast cancer survivors
Time of Update: 2022-10-25
It can be seen that among breast cancer survivors in Korea, endocrine therapy is associated with a high risk of cardiovascular disease and type 2 diabetes.
among breast cancer survivors in Korea, endocrine therapy is associated with a high risk of cardiovascular disease and type 2 diabetes.
-
Make the weapons of cancer cells harmless
Time of Update: 2022-09-09
"Instead, ATP will accumulate around cancer cells, which actually stimulates the immune response," Müller said.
"Instead, ATP will accumulate around cancer cells, which actually stimulates the immune response," Müller said.
"Instead, ATP will accumulate around cancer cells, which actually stimulates the immune response," Müller said.
-
Innovative IgA Nephropathy Therapy Receives Accelerated FDA Approval
Time of Update: 2022-01-11
Retrieved December 15, 2021, from https:// -protein-iga-nephropathy-rare-kidney-disease[2] FDA grants Calliditas Therapeutics Accelerated Approval of TARPEYO™ (budesonide) to Reduce Proteinuria in IgA Nephropathy.
-
The Institute of Biology, Beijing Academy of Agriculture and Forestry Sciences has made important progress in research on the regulation of Alzheimer's disease by zeoflavone isoorientin
Time of Update: 2021-11-01
The study revealed that isoorientin, a natural product of corn filaments, regulates the oral and intestinal microbes of Alzheimer's disease model mice, thereby inhibiting the NF-κB inflammatory pathway, and ultimately slowing down Alzheimer's disease-related diseases through the brain-gut axis Pathological indicators .
-
Immune checkpoints and autoimmune diseases
Time of Update: 2021-08-26
ICP Targeted Therapy of Autoimmune Disease Research Progress Soluble ICP Ligand and Receptor Soluble ICP Ligand and ReceptorSource Reference 1Source Reference 1In 2006, Abatacept was first approved for the treatment of RA.
-
Professor Zhao Futao: From the outside to the inside, let you have a more comprehensive understanding of Sjogren’s syndrome
Time of Update: 2021-04-28
"Benefiting from a large number of basic research and clinical research data support (Table 2), the 2020 "Primary Sjogren’s Syndrome Guidelines" will include IGU in the recommended list of immunomodulators, and indicated that SS patients with systemic involvement can use it.
-
Clin Gastroenterology H: Diet therapy can induce rapid remission in children with active Crohn's disease
Time of Update: 2021-04-13
This study confirmed that for pediatric patients with CD in the active stage of disease, diet therapy (CDED and EEN) can quickly induce disease remission.
This study confirmed that for pediatric patients with CD in the active stage of disease, diet therapy (CDED and EEN) can quickly induce disease remission.
-
HCV from discovery to conquest - a game between humans and viruses
Time of Update: 2020-10-19
Les's discovery in the journal Science in 1997 that the establishment of HCV cell line broke the bottleneck for new drug screening Although Professor Rice and his team first verified the infectiousness of the RNA virus in animal models, it was still a long way from replicating HCV in the lab.
-
Why does everyone feel different in pain? Genetic variation can affect pain differences
Time of Update: 2020-08-07
there was no technology to determine the cause of the disease, but we know from these rare families that congenital pain insensitivity is due to specific mutations or deletions of individual genes needed to transmit pain signals.
-
No chloroquine/hydroxychloroquine prevention or treatment of COVID-19 is recommended, and look at the 10 studies summarized in the Annals of Internal Medicine
Time of Update: 2020-06-21
The preliminary results of in vitro and clinical studies on the prevention or treatment of COVID-19 in the case of chloroquine/hydroxychloroquine alone or a combination of azithromycin have received
-
Science Major Advances: New Ways to Treat Arthritis and Other Inflammatory Diseases
Time of Update: 2020-05-12
May 12, 2020 / PRNewswire BIOON // Researchers from the Peter McCallum Cancer Center have found an innovative way to suppress severe inflammation in mice, offering a potential new way to treat infl
-
Brit J Pharmacol: marijuana has many anti-cancer effects
Time of Update: 2018-07-18
July 18, 2018 / BIOON / - past studies have shown that cannabis can help reduce the side effects of anti-cancer therapy, while a new review published in British Journal of pharmacology summarizes the
-
Immunogen and Takeda pharmaceutical reached a $440 million ADC cooperation agreement
Time of Update: 2015-03-24
Source: Biovalley, March 24, 2015, after a long silence, immunogen, a famous pharmaceutical company, finally received another major good The company announced a cooperation agreement with Japanese pha
-
The refined fish oil extract is licensed by QS
Time of Update: 2014-10-27
Recently, the healthy fish oil product (refined fish oil extract) jointly developed by Hebei kangruida lipid Co., Ltd together with experts from Ocean University of China, Tianjin University and Hebei
